Other

Acquisition-related cash and share-based compensation costs

Cardinal Health Acquisition-related cash and share-based compensation costs increased by 67.2% to $112.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 460.0%, from $20.00M to $112.00M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalLower is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ3 2026Apr 30, 2026

How to read this metric

High levels suggest aggressive M&A integration or retention efforts, which may be necessary for deal success but increase short-term expenses.

Detailed definition

This represents cash payments and equity-based compensation specifically tied to acquisition agreements, such as retenti...

Peer comparison

Specific to companies with frequent M&A; often categorized under acquisition-related adjustments.

Metric ID: other_acquisition_related_cash_and_share_based_compensat_c19819

Historical Data

15 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$131.00M$20.00M$106.00M$64.00M$67.00M$112.00M
QoQ Change-84.7%+430.0%-39.6%+4.7%+67.2%
YoY Change-48.9%+460.0%
Range$0.00$131.00M
Avg YoY Growth+205.6%
Median YoY Growth+205.6%
Current Streak2 quarters growth

Frequently Asked Questions

What is Cardinal Health's acquisition-related cash and share-based compensation costs?
Cardinal Health (CAH) reported acquisition-related cash and share-based compensation costs of $112.00M in Q1 2026.
How has Cardinal Health's acquisition-related cash and share-based compensation costs changed year-over-year?
Cardinal Health's acquisition-related cash and share-based compensation costs increased by 460.0% year-over-year, from $20.00M to $112.00M.
What does acquisition-related cash and share-based compensation costs mean?
Compensation costs specifically paid to employees or executives as part of an acquisition deal.